Preparing clinician-scientists to become leaders in clinical pharmacology research
People
Jump below to
Faculty
Fellows work with research and clinical faculty members at UCSF—a world-renowned institution exclusively focused on health sciences.
- Nadav Ahituv, PhD
- Fran T. Aweeka, PharmD
- Sourav Bandyopadhyay, PhD
- Leslie Z. Benet, PhD
- Neal L. Benowitz, MD
- Kristen Bibbins-Domingo, MD, PhD
- Atul Butte, MD, PhD
- Amelia Deitchman, PharmD, PhD
- Grant Dorsey, MD
- Timur Durrani, MD, MPH
- Leslie Carstensen Floren, PharmD
- Kathleen M. Giacomini, PhD
- Timothy Henrich, MD
- Ronald Krauss, MD
- Janel Long-Boyle, PharmD, PhD
- Pamela N. Munster, MD
- Akinyemi Oni-Orisan, PharmD, PhD
- Kathryn A. Phillips, PhD, MPA
- Jennifer M. Puck, MD
- Philip Rosenthal, MD
- Nancy C. Sambol, PharmD
- Rada Savic, PhD
- Janice B. Schwartz, MD
- Marina Sirota, PhD
- Eric Small, MD
- Bani Tamraz, PharmD, PhD
- Gustavo Velasquez, MD, MPH
- Joshua Woolley, MD, PhD
- Alan H. Wu, PhD
- Elad Ziv, MD
Current postdoctoral scholars and fellows
|
Photo |
Who |
Research interests |
|---|---|---|
|
Anita Chaphekar, DO Clinical Pharmacology Fellow |
Psilocybin-assisted psychotherapy as a novel treatment in anorexia nervosa |
|
Ryo Miyakawa, MD, MPH Clinical Pharmacology Fellow |
Improving dosing strategy of antimycobacterial medications. |
|
Dvijen Purohit, PharmD, MS Clinical Pharmacology Fellow [email protected] |
Apply computational approaches and model-based drug development to inform chemotherapeutic management of tuberculosis in patients globally. |
|
Andrew Riselli, PharmD Clinical Pharmacology Fellow [email protected] |
Using biomarkers to characterize transporter-mediated drug-drug interactions and polymorphisms in membrane transporter genes; physiologically-based pharmacokinetic modeling |
|
Maureen Shin, PharmD, MS Clinical Pharmacology Fellow |
Dose optimization via population pharmacokinetic (PK) modeling in pediatric infectious disease and oncology patients |
|
Markus Ville Tiitto, PharmD, PhD Clinical Pharmacology Fellow |
Effect of parenteral drug administration absorption rates on systemic absorption (AUC) |
|
Michelle Wang, PharmD, PhD Clinical Pharmacology Fellow |
Using novel artificial intelligence computational methods to study real-world data to improve the use of novel therapeutics. |
Former fellows
|
Who, Years mentored |
Now |
Main research |
|---|---|---|
|
Folagbayi Arowolo, PhD |
precision medicine and optimization of drug dosing regimens using mass spectrometry | |
|
Jordan Brooks, PharmD July 2021 - April 2023 |
Pharmacometrician / Data Scientist at InsightRX | Developing computational models to improve medication use in children, translating models into clinical applications that improve efficacy and minimize toxicity from medications used in pediatric hematopoietic stem cell transplantation. |
| Isaac Cohen PharmD July 2018 - May 2020 |
Population PK modeling of antibiotics, retrospective analysis of postoperative pain management, and advising psychiatric drug development | |
|
Amelia Deitchman PharmD, PhD |
Assistant Professor, UCSF Clinical Pharmacy | clinical and translational pharmacology and pharmacometrics to understand drug action and variability to improve patient outcomes and streamline drug development in the setting of infectious disease, specifically tuberculosis, HIV, and malaria |
| Elizabeth Ennis, PhD | Pharmacologist, U.S. Food and Drug Administration |
genetic determinants of metformin pharmacokinetics, and drug-transporter interactions |
| Briana Fitch, PhD July 2019- June 2021 |
Therapeutic drug monitoring of anticoagulants, clinical applications of mass spectrometry, and prognostic value of inflammatory markers in infectious disease and cancer. | |
| Priya Jayachandran, PharmD, MSE July 2017- June 2020 |
Pharmacometrician at Pfizer |
pharmacokinetic / pharmacodynamic modeling of drug response, infectious diseases, pediatrics, study design, global health |
| Eunice Lee, PhD | Fellow, National Institutes of Health |
environmental and molecular epidemiology, gene-environment interactions, biomarkers of exposure to air pollution, drug response |
|
Kendra Radtke, PharmD July 2021 - June 2023 |
Apply novel computational approaches to inform dosing and therapeutic management of infectious diseases in special populations such as children and pregnant women. | |
| Lesly-Anne Samedy, PharmD, PhD, MS July 2017-June 2020 |
Program Officer, National Institutes of Health (NICHD) |
pharmacogenetics and epigenetic factors in the development of asthma in admixed populations; pharmacodynamics, pharmacokinetics, and drug response; genetic variant associations; health disparities |
| Erika Wallender, MD, MPH |
|
pharmacokinetic and pharmacodynamic modeling to optimize antimalarial use for malaria treatment and prevention in children in Uganda |
| Jonathan Witonsky, MD, MPH July 2019-June 2020 |
UCSF Pediatric Allergy and Immunology Clinical Instructor and Clinical Research Informatics Postdoctoral Research Fellow | genetic and epigenetic factors in the development of asthma, pulmonary function testing in admixed populations, and health disparities in clinical research |
| Eric Wolford, MD, MPH July 2019-March 2021 |
Genetic and microbial factors associated with immune-mediated diseases including asthma in children. Interests include improving disparities in research and clinical care for minority populations, with an aim to make personalized medicine available to all population | |
|
Yasmine White, MD July 2020 - June 2023 |
Pharmaceuticals for birth asphyxia, pharmacokinetic/pharmacodynamic modeling in neonates | |
| Yu “Jada” Zhang, MD, PhD July 2019-March 2021 |